The sentinel within: exploiting the immune system for cancer biomarkers.
about
Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screeningPotential biomarkers for esophageal cancerProspective health care: the second transformation of medicineRapid detection of antibodies in sera using multiplexed self-assembling bead arraysMicroelectrical sensors as emerging platforms for protein biomarker detection in point-of-care diagnostics.Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization Strategies.Linking the ovarian cancer transcriptome and immunomeIdentification of tumor-associated antigens as diagnostic and predictive biomarkers in cancer.Immunoscreening of the extracellular proteome of colorectal cancer cells.Peptides from the variable region of specific antibodies are shared among lung cancer patients.Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigensHumoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer.Differential Plasma Glycoproteome of p19 Skin Cancer Mouse Model Using the Corra Label-Free LC-MS Proteomics PlatformRapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigens.Complement factor H autoantibodies are associated with early stage NSCLC.Immunogenicity of autoantigens.Glycopeptide microarray for autoantibody detection in cancer.Tumor-associated autoantibodies as diagnostic and prognostic biomarkers.Preliminary study of thyroid and colon cancers-associated antigens and their cognate autoantibodies as potential cancer biomarkers.Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis.Antibody repertoire profiling using bacterial display identifies reactivity signatures of celiac disease.Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays.Identification of differentially expressed proteins in ovarian cancer using high-density protein microarraysA microarray method for identifying tumor antigens by screening a tumor cDNA expression library against cancer sera.Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers.Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancerAutoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.Serological proteome analysis of dogs with breast cancer unveils common serum biomarkers with human counterparts.Autoantibody signature for the serologic detection of ovarian cancerApplications of protein microarrays for biomarker discovery.Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer.Tracking humoral responses using self assembling protein microarraysChemical tools to monitor and manipulate the adaptive immune system.Autoantibody signatures: progress and perspectives for early cancer detectionHigh affinity binding of conformationally constrained synthetic oligomers to an antigen-specific antibody: Discovery of a diagnostically useful synthetic ligand for murine Type 1 diabetes autoantibodies.Dicarbonyl Induced Structural Perturbations Make Histone H1 Highly Immunogenic and Generate an Auto-Immune Response in CancerPlasma Autoantibodies Associated with Basal-like Breast Cancers.
P2860
Q24630334-70A3FCF1-804B-4C27-91F4-43774DE7EAA4Q26749416-909BA05A-6FF4-415E-AF43-753C4FFBAF21Q28300742-4EFDE4FA-7195-435C-A183-DA71EA441DEBQ28384360-60464952-C0B8-4713-9E61-F6C6FD6875F6Q30480197-F7229189-8235-4BE4-80D9-56EAE3C61DCCQ31126986-B0B7922B-CE33-4350-BCEC-DE4AE182136EQ33313203-CC765A70-8CDE-45FE-A916-87CD8D221ED7Q33432974-472BE013-43AB-40B8-8FFE-0D1A45D0289DQ33534464-530C2493-3F4F-42E8-B093-7D8581F2C21FQ33553735-8EA7667F-3168-4B64-B7AC-849D7C3D2491Q33594076-3DED0795-78B5-47B0-B1B8-AD54131CF308Q33608271-BF5588A9-AA30-4015-8681-BDD62044154CQ33649446-6D8B4B2C-F6C3-41FB-A5DC-9D7A2866AF7EQ33691051-9392A763-15C0-4199-8B13-65BEF8D84A3CQ33725961-4A2D3B8F-CE0F-47AF-A488-A1204DB39934Q33747137-364AA36C-9D43-463E-A058-A93B98EBB2FDQ33937882-ABE7E627-3F12-4DA1-A5D2-E39A5F1B09D2Q33949907-861E3335-2D12-4576-91E8-B878650BB6F8Q33983835-BC0B223C-D39C-4387-98B9-E9D3982EAFDEQ34049184-C53B2D04-C61B-4EAA-8F7C-954D5B68980AQ34276070-D443E672-7F4C-4ED7-8C85-57949316C7EAQ34309299-C84DF644-B142-4839-B5C1-4F741D3332B8Q34509614-403F94AE-E50F-40B0-AFAA-0FF36FCC7E00Q34618619-EDB7BB50-6D2D-405B-9B50-B7702AD95B78Q34705309-3271BB7D-87A4-45D7-B4C1-C98CA231BDB9Q34817494-3251024A-2586-4EFA-BB02-3B86551A6692Q34826137-FCEDF389-24B4-4F3C-BBE5-A2A83859F4FAQ35018525-D02D06F3-CD11-410D-A452-CBF4B6FC569EQ35034741-D3BF4B07-B294-48B5-B44A-0579EABC2216Q35059164-D64EE40E-8BE4-471B-9E5E-2AA885722FACQ35066912-FC7BDFA4-91E9-4921-9793-36E386B90A28Q35100846-6A3DBBD6-A76A-4794-BD6E-3E0BE7090A53Q35170387-DD08D525-507F-4D75-8722-6875D23D815CQ35170389-F5D7DBAA-6591-4901-869D-E13A7FE9BC79Q35170395-51BF4E9F-6FCA-41FB-8079-268F0D70E6AFQ35264291-D19D7A85-ECC5-4312-972D-0E244068F87AQ35377236-C2EC508D-318D-4FD1-A2C8-0C5D94EF11EAQ35661419-D8A7A3FB-ABFD-43C5-BBC3-39C83B01F7E2Q35759066-EECD2ED4-AEA7-4BE8-BA8B-2E8AE676A69DQ36029610-93211330-62E9-471E-96AA-25F43A056E1A
P2860
The sentinel within: exploiting the immune system for cancer biomarkers.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The sentinel within: exploiting the immune system for cancer biomarkers.
@ast
The sentinel within: exploiting the immune system for cancer biomarkers.
@en
type
label
The sentinel within: exploiting the immune system for cancer biomarkers.
@ast
The sentinel within: exploiting the immune system for cancer biomarkers.
@en
prefLabel
The sentinel within: exploiting the immune system for cancer biomarkers.
@ast
The sentinel within: exploiting the immune system for cancer biomarkers.
@en
P2860
P356
P1476
The sentinel within: exploiting the immune system for cancer biomarkers.
@en
P2093
Karen S Anderson
P2860
P304
P356
10.1021/PR0500814
P577
2005-07-01T00:00:00Z